Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Serum Oxidative Stress Biomarkers in Pemphigus Vulgaris: Clinical Insights and Implications for Pathogenesis. | Dermatol Pract Concept | 2025 | 40790427 | PubTator, text mining | PubMed |
| SEDCYDO - SEGER - SEMO CONGRESS MADRID 2025, 8-10 MAY. Proceedings and Abstract. | Med Oral Patol Oral Cir Bucal | 2025 | 40767450 | PubTator, text mining | PubMed |
| Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma. | BMC Cancer | 2025 | 40751234 | PubTator, text mining | PubMed |
| Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. | Hum Vaccin Immunother | 2025 | 40747591 | PubTator, text mining | PubMed |
| Desmosomal cadherin tension loss in pemphigus vulgaris mediated by the inhibition of active RhoA at cell-cell adhesions. | iScience | 2025 | 40740498 | PubTator, text mining | PubMed |
| Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review. | Clin Cosmet Investig Dermatol | 2025 | 40734984 | PubTator, text mining | PubMed |
| Desmoglein 1 and 3 as potential markers of occult lymph node metastasis in oral cancer. | J Oral Maxillofac Pathol | 2025 | 40703823 | PubTator, text mining | PubMed |
| Assessment of Efficacy of Adjuvant Topical Rituximab Encapsulated in Nanoparticle Gel in Oral Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled, Pilot Study. | Indian Dermatol Online J | 2025 | 40688121 | PubTator, text mining | PubMed |
| Editorial: Community series in autoantibodies, volume II. | Front Immunol | 2025 | 40672950 | PubTator, text mining | PubMed |
| Evaluation of total sulfhydryl levels and dietary habits in pemphigus vulgaris. | Postepy Dermatol Alergol | 2025 | 40672734 | PubTator, text mining | PubMed |
| Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid. | Front Immunol | 2025 | 40661962 | PubTator, text mining | PubMed |
| G4-SLSELEX-Seq-driven discovery of a G4-specific targeting L-RNA aptamer with unique structural features. | Org Biomol Chem | 2025 | 40637089 | PubTator, text mining | PubMed |
| DSG3 promotes bladder cancer growth and metastasis via AKT/GSK3β/β-catenin pathway. | J Transl Med | 2025 | 40605005 | PubTator, text mining | PubMed |
| Identification of plasma proteins associated with seizures in epilepsy: A consensus machine learning approach. | PLoS One | 2025 | 40591616 | PubTator, text mining | PubMed |
Comparison of anti-desmoglein antibodies titres and anti-M3 muscarinic acetylcholine receptor antibody titres as biomarker for potential pemphigus between subjects who are occupationally exposed and not exposed to pesticides. | Indian J Dermatol Venereol Leprol | 2025 | 40587540 | PubTator, text mining | PubMed |
| Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: a case report and literature review. | Dermatol Reports | 2025 | 40576630 | PubTator, text mining | PubMed |
| Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review. | Antibodies (Basel) | 2025 | 40558105 | PubTator, text mining | PubMed |
| Desmoglein-3 autoantibodies in tissues of oral lichen planus patients and its correlation with disease severity: case-control study. | BMC Oral Health | 2025 | 40481453 | PubTator, text mining | PubMed |
| Engineered extracellular vesicles derived from pluripotent stem cells: a cell-free approach to regenerative medicine. | Burns Trauma | 2025 | 40475972 | PubTator, text mining | PubMed |
| RNA G-quadruplex structure targeting and imaging: recent advances and future directions. | RNA | 2025 | 40473419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=5